Market overview
The global AI aortic surgery planning tool market is worth USD 55 mn in 2026 and is forecast to reach USD 186 mn by 2036, growing at a 13.0% CAGR. United States is the largest country market and Endovascular aneurysm repair is the largest by procedure segment.
| Scope | Software that uses artificial intelligence to plan aortic repair: sizing of stent grafts, 3D reconstruction from CT and fusion guidance used before and during open and endovascular surgery. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 48 mn |
| Value 2026 | USD 55 mn |
| Value 2036 | USD 186 mn |
| CAGR 2026-2036 | 13.0% |
| Volume 2026 | 2,052 installations |
| Volume 2036 | 6,966 installations |
| Average price 2026 | USD 26,670 per installation |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
AI Aortic Surgery Planning Tool market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 55 mn |
| 2027 | USD 62 mn |
| 2028 | USD 70 mn |
| 2029 | USD 79 mn |
| 2030 | USD 89 mn |
| 2031 | USD 101 mn |
| 2032 | USD 114 mn |
| 2033 | USD 129 mn |
| 2034 | USD 145 mn |
| 2035 | USD 164 mn |
| 2036 | USD 186 mn |
AI Aortic Surgery Planning Tool market segmentation
By procedure
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Endovascular aneurysm repair | 58.0% | 60.6% | USD 32 mn | 13.5% |
| Thoracic aortic repair | 26.0% | 26.0% | USD 14 mn | 13.0% |
| Open surgery planning | 16.0% | 13.4% | USD 8.8 mn | 11.0% |
By user
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 72.0% | 72.2% | USD 39 mn | 13.0% |
| Device makers | 16.0% | 14.7% | USD 8.8 mn | 12.0% |
| Imaging centres | 12.0% | 13.1% | USD 6.6 mn | 14.0% |
By deployment
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Cloud | 52.0% | 56.0% | USD 28 mn | 13.8% |
| On-premise | 30.0% | 26.0% | USD 16 mn | 11.4% |
| Hybrid | 18.0% | 18.0% | USD 9.8 mn | 13.0% |
By component
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Software licence | 58.0% | 56.0% | USD 32 mn | 12.6% |
| Services and training | 24.0% | 25.0% | USD 13 mn | 13.5% |
| Workstation and integration | 18.0% | 19.0% | USD 9.8 mn | 13.6% |
By pricing model
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Subscription | 42.0% | 46.0% | USD 23 mn | 14.0% |
| Per-case fee | 30.0% | 30.0% | USD 16 mn | 13.0% |
| Perpetual licence | 28.0% | 24.0% | USD 15 mn | 11.3% |
Top 25 countries for AI aortic surgery planning tool by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.5% of 2026 revenue and the 25 countries below together hold 97.2%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 22 mn | 40.0% | USD 71 mn | 12.4% |
| 2 | Germany | USD 4.9 mn | 9.0% | USD 17 mn | 13.0% |
| 3 | Japan | USD 4.4 mn | 8.0% | USD 14 mn | 12.0% |
| 4 | United Kingdom | USD 3.8 mn | 7.0% | USD 14 mn | 13.5% |
| 5 | France | USD 3.3 mn | 6.0% | USD 11 mn | 13.0% |
| 6 | China | USD 3.3 mn | 6.0% | USD 16 mn | 17.0% |
| 7 | Italy | USD 2.2 mn | 4.0% | USD 7.4 mn | 13.0% |
| 8 | Netherlands | USD 1.9 mn | 3.5% | USD 6.5 mn | 13.0% |
| 9 | Canada | USD 1.6 mn | 3.0% | USD 5.6 mn | 13.0% |
| 10 | Australia | USD 1.6 mn | 3.0% | USD 5.8 mn | 13.4% |
| 11 | Spain | USD 0.44 mn | 0.8% | USD 1.4 mn | 12.1% |
| 12 | Switzerland | USD 0.41 mn | 0.8% | USD 1.3 mn | 12.1% |
| 13 | Sweden | USD 0.33 mn | 0.6% | USD 1.0 mn | 12.0% |
| 14 | Belgium | USD 0.33 mn | 0.6% | USD 1.0 mn | 12.0% |
| 15 | South Korea | USD 0.33 mn | 0.6% | USD 1.2 mn | 13.4% |
| 16 | Denmark | USD 0.30 mn | 0.5% | USD 0.93 mn | 12.1% |
| 17 | Austria | USD 0.30 mn | 0.5% | USD 0.93 mn | 12.1% |
| 18 | Israel | USD 0.26 mn | 0.5% | USD 0.91 mn | 13.5% |
| 19 | Brazil | USD 0.22 mn | 0.4% | USD 0.85 mn | 14.3% |
| 20 | India | USD 0.22 mn | 0.4% | USD 0.95 mn | 15.5% |
| 21 | Singapore | USD 0.22 mn | 0.4% | USD 0.78 mn | 13.3% |
| 22 | Norway | USD 0.22 mn | 0.4% | USD 0.69 mn | 11.8% |
| 23 | Taiwan | USD 0.22 mn | 0.4% | USD 0.78 mn | 13.3% |
| 24 | Poland | USD 0.19 mn | 0.3% | USD 0.65 mn | 13.3% |
| 25 | Turkey | USD 0.19 mn | 0.3% | USD 0.72 mn | 14.6% |
| Rest of world | USD 1.6 mn | 2.8% | USD 4.8 mn | 12.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Siemens Healthineers
- Philips
- TeraRecon
- GE HealthCare
- Canon Medical Systems
- Medtronic
Group 2: Regional and specialist players
- Materialise
- Pie Medical Imaging
- Cydar Medical
- Therenva
- Circle Cardiovascular Imaging
- Medis Medical Imaging
- Cook Medical
- W. L. Gore & Associates
- Aidoc
Group 3: Emerging and niche players
- Fluidda
- Aortica Corporation
- Predisurge
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the AI aortic surgery planning tool market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 13.0% is calculated from the resulting values.
The market is divided by procedure, by user, by deployment, by component, by pricing model. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the AI aortic surgery planning tool market?
The global AI aortic surgery planning tool market is estimated at USD 48 mn in 2025 and USD 55 mn in 2026.
How fast will the AI aortic surgery planning tool market grow?
It is forecast to reach USD 186 mn by 2036, a compound annual growth rate of 13.0% from 2026, an increase of USD 131 mn.
Which country is the largest market for AI aortic surgery planning tool?
United States is the largest market by revenue at USD 22 mn in 2026, 40.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 17.0% a year from 2026 to 2036.
Which AI aortic surgery planning tool segment is largest?
In the by procedure split, Endovascular aneurysm repair is the largest segment with 58.0% of 2026 revenue.
Who are the leading AI aortic surgery planning tool companies?
Global leaders include Siemens Healthineers, Philips, TeraRecon, GE HealthCare.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Colorimetric Fructosamine Assay KitUSD 57 mn · 4.8% CAGR
- At-Home Syphilis TestingUSD 58 mn · 24.0% CAGR
- Blood Bag Tube SealerUSD 58 mn · 4.5% CAGR
- Digital Colony CounterUSD 59 mn · 5.5% CAGR
- Amyotrophic Lateral Sclerosis Gene TestingUSD 62 mn · 10.5% CAGR
- Respiration Monitor BeltUSD 63 mn · 5.2% CAGR
- AI Capsule Endoscopy Reading PlatformUSD 64 mn · 17.0% CAGR
- Touch Activated Phlebotomy DevicesUSD 72 mn · 18.0% CAGR
← 3D Imaging Surgical Solution AI Capsule Endoscopy Reading Platform →